Number of the records: 1  

Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia

  1. TitleIncreased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia
    Author Babušíková Oľga 1940-2011 SAVEXONK - Ústav experimentálnej onkológie SAV
    Co-authors Števulová Libuša SAVEXONK - Ústav experimentálnej onkológie SAV

    Železníková Tatiana 1970- SAVEXONK - Ústav experimentálnej onkológie SAV

    Co-authors Kovariková Anna
    Source document Neoplasma. Vol. 54, no. 6 (2007), p. 471-477
    Languageeng - English
    CountrySK - Slovak Republic
    Document kindrozpis článkov z periodík (rbx)
    CitationsREIS, S. C. - TRAINA, F. - METZE, K. - SAAD, S. T. O. - LORAND-METZE, I. VARIATION OF BONE MARROW CD34+ CELL SUBSETS IN MYELODYSPLASTIC SYNDROMES ACCORDING TO WHO TYPES. In NEOPLASMA. ISSN 0028-2685, 2009, vol. 56, no. 5, pp. 435.
    HOURIGAN, Christopher S. - KARP, Judith E. Minimal residual disease in acute myeloid leukaemia. In NATURE REVIEWS CLINICAL ONCOLOGY. ISSN 1759-4774, 2013, vol. 10, no. 8, pp. 460.
    LIAO, Hongyan - ZHENG, Qin - JIN, Yongmei - CHOZOM, Tashi - ZHU, Ying - LIU, Li - JIANG, Nenggang. The prognostic significance of hematogones and CD34+myeloblasts in bone marrow for adult B-cell lymphoblastic leukemia without minimal residual disease. In SCIENTIFIC REPORTS. ISSN 2045-2322, 2019, vol. 9, no., pp.
    CategoryADDA - Scientific papers in domestic journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2007
    Registered inWOS
    Registered inSCOPUS
    unrecognised

    unrecognised

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    200720061.247Q40.483Q3
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.